AG
MR

Aperio Group’s MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A MR Stock Holding History

Aperio Group’s Portfolio MR Stock Details MR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-53,690
Closed -$1.46M – 2108
2015
Q4 		$1.46M Sell
53,690
-10,270
-16% -$265K 0.01% 867
2015
Q3 		$1.4M Sell
63,960
-84,090
-57% -$2.15M 0.01% 849
2015
Q2 		$4.22M Buy
148,050
+69,621
+89% +$2.03M 0.04% 470
2015
Q1 		$2.15M Buy
78,429
+35,310
+82% +$972K 0.02% 657
2014
Q4 		$1.14M Sell
43,119
-7,420
-15% -$217K 0.01% 851
2014
Q3 		$1.52M Buy
50,539
+11,184
+28% +$346K 0.02% 692
2014
Q2 		$1.24M Sell
39,355
-2,143
-5% -$68K 0.02% 761
2014
Q1 		$1.34M Buy
+41,498
New +$1.45M 0.02% 858
2013
Q4 		– Hold
0
– – – 1001

Other funds holding MR

Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Aperio Group's MR Position: Q1 2016 in Review

Aperio Group sold out of MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A (MR) in Q1 2016, closing a stake of 53,690 shares — an estimated $1.46M sold.

Aperio Group first reported a position in MR in Q1 2014 and held it in 8 quarters. The position peaked at $4.22M in Q2 2015. 2 funds tracked by Wall St. Rank hold MR as of Q1 2016.

  • Aperio Group reported no remaining MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A position as of Q1 2016 after selling out during the quarter.
  • Aperio Group sold 53,690 MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A shares in Q1 2016, an estimated $1.46M.
  • Aperio Group first reported a position in MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A in Q1 2014 and held it in 8 quarters.
  • Aperio Group's MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A position peaked at $4.22M in Q2 2015.
  • 2 funds tracked by Wall St. Rank held MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A as of Q1 2016.

Based on Aperio Group's 13F filing for Q1 2016, filed 28 Apr 2016.